Tiger Shroff took to Twitter to share his look from the upcoming action-thriller, Ganapath, wherein he performs the titular position. In the movement poster, the world round him could possibly be seen burning, whereas he sat on a big chair and gazed into the space. His shirt was unbuttoned, giving a glimpse of his chiselled abs, and he held a lit cigarette.
In a voiceover, Tiger stated, “Jab apun darta hai na, tab apun bohot maarta hai (When I get scared, I hit a lot).” Sharing the movement poster, the actor wrote on Twitter, “Yaaron ka yaar hu, dushmano ka baap hu (I am the best friend to friends, I am my enemies’ worst foe)! Presenting #GanapathFirstLook. #VikasBahl @vashubhagnani @jackkybhagnani @honeybhagnani #GoodCo @poojafilms.”
Earlier this month, Tiger declare that he’ll headline a new motion franchise, Ganapath, which shall be directed by Vikas Bahl. The first part shall be set in a post-pandemic, dystopian world.
Also study | Kangana Ranaut responds to followers who need her to remain quiet on Twitter, are bored with her tweets: ‘Don’t love me like a hater’
Tiger had stated in a press release, “This film is different for me from the rest of the films I’ve done till date because of the character I play. After multiple conversations with Vikas and Jackky (Bhagnani), the script and scale look promising. I am really looking forward to this one. This will be my first time working with Jackky and Vikas and it will be hugely exciting to collaborate with them.”
Jackky, one of many co-producers of Ganapath, had stated, “I look at Tiger as a global star. He has all the potential and every ingredient that makes him unique and sets him apart. His films have slick action with an international flavour that appeals to audiences all over the world. I am sure the combination of Vikas and Tiger will make magic and redefine the action genre.”
Ganapath shall be produced by Vashu Bhagnani, Vikas Bahl, Deepshikha Deshmukh and Jackky Bhagnani. The movie will go on flooring in mid-2021 and can launch in 2022.
Follow @TheNewsEveryda1 for further